Bonti is a biopharmaceutical company that researches and develops novel therapeutics for the treatment of focal muscle pain... Read more
Bonti is a biopharmaceutical company that researches and develops novel therapeutics for the treatment of focal muscle pain... Read more
News
Sep 21, 2018
Asian Venture Capital Journal
Bonti: China's HighLight to exit US-based biotech player Bonti
Sep 14, 2018
Business & Finance
Bonti: Coillte selling wind farm assets to Greencoat Renewables plc for €281 million Enterprise Value
Aug 23, 2018
BioPortfolio
Bonti: Bonti Announces Presentation Featuring EB001A at Masters of Aesthetics Symposium
Aug 02, 2018
BioPortfolio
Bonti: Bonti Announces Successful Completion of Phase 2a Scar Reduction Clinical Study
May 09, 2018
BioPortfolio
Bonti: Bonti Announces Start of LANTERN2 Phase 2 Clinical Trial Evaluating EB001T in Treating Focal Muscle Pain
Apr 25, 2018
BioPortfolio
Bonti: Bonti Announces Scientific Presentation at Premier Aesthetic Plastic Surgery Conference
Feb 12, 2018
StreetInsider
Press Release: Bonti : Bonti Appoints Dr. Jacob Chacko to Board of Directors
Feb 12, 2018
PharmiWeb
Bonti: Bonti Appoints Dr. Jacob Chacko to Board of Directors
Feb 08, 2018
PharmiWeb
Bonti: Bonti Announces Dosing of the First Patient in the SHINE-1 Phase 2 Clinical Study Evaluating EB-001 for Scar Reduction
Feb 05, 2018
Orange County Business Journal
Bonti: Bonti Bets Big on Therapeutic Botox
Bonti, Inc., Competitors
1
2
3
4
5
6
7
8
9
10